The global regime for intellectual property (IP) operates under multilateral agreements in conjunction with unilateral national policies. Chief among the multilateral frameworks is the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which is considered the most comprehensive agreement on intellectual property.
The TRIPS Agreement, which came into force in 1995, is a multilateral instrument that covers seven forms of IP: copyrights, trademarks, geographical indications, industrial designs, patents, layout-designs of integrated circuits, and undisclosed information (trade secrets).It applies to all WTO member nations, requiring them to implement its provisions within their legal systems.
The TRIPS Agreement is a multilateral framework, which: (i) defines the minimum standards for I.P. protection and enforcement among WTO members; (ii) includes measures for incentivizing innovation; (iii) balances public interest with the interests of IP owners(e.g., access to medicines and public health); and, (iv) provides for dispute settlement and technical cooperation to ensure widespread IP protection.
Key principles and provisions of the TRIPS Agreement include:
TRIPS also recognizes that IPR protection is not one-size-fits-all process. Therefore, it allows member-countries to adapt laws to suit their specific developmental stages and policy priorities. In other words, TRIPS affords member-nations the discretion to provide more extensive IP protection than the minimum standards set by the agreement.
Alongside the TRIPS framework, the United States employs its own mechanism—the Special 301 Report, issued annually by the Office of the United States Trade Representative (USTR)—to identify and pressure countries that, in its view, do not offer "adequate and effective" protection for U.S. IP rights or deny fair access to U.S. entities.
The stated aim of the Special 301 Report is to improve global IPR enforcement. Neutral observers though are critical of the unilateral nature, pressure tactics, and inherent bias toward U.S. commercial interests, which often are at odds with the TRIPS Agreement that is rooted in multilateralism, sovereign flexibility, and a balanced approach to IP protection.
The Special 301 Report derives its authority from Section 182 of the U.S. Trade Act of 1974.It empowers the USTR to identify member-countries whose IP regimes inadequately protect U.S. interests. These countries are categorized into: (i) Priority Foreign Countries (highest concern); (ii) Priority Watch List; and,(iii) Watch List. USTR also recommends bilateral action plans, capacity building, or even trade sanctions against the identified member-countries.
In its 2025 edition, the USTR listed 8countries on the “Priority Watch List”, which included China, India, Russia, and Argentina. Another 18 countries were placed on the Watch List, which included Canada, Brazil, Egypt, besides Vietnam. These countries were singled out for various issues, ranging from online piracy and counterfeit goods to patent backlog and weak judicial enforcement.
The U.S. often follows up the Section 301 Report with investigations, bilateral dialogues, and technical assistance. Such investigations have at times led to the imposition of tariffs, sanctions or restrictions. Countries like India and Indonesia are subjects of action plans of bilateral checklists and benchmarks. Framed as support, technical assistance & capacity building measures are sometimes seen as a veiled attempt to shape national IP policy.
It is argued by proponents that these unilateral actions are potent diplomatic tools—based solely on U.S. standards and enforcement priorities. While occasionally followed by WTO disputes, many of these measures bypass formal dispute resolution and exert economic pressure, raising serious legitimacy and fairness concerns.
Given the TRIPS framework, the lack of alignment of the Special 301 Report with WTO principles and mechanisms is an issue for global IP governance. The real-world implications of the mismatch are far-reaching. The conflict with the foundational philosophy of the Agreement is of concern and pertains to the following aspects:
The Bias toward U.S. Industry is amply evident. The report is often viewed as prioritizing U.S. corporate interests—particularly pharmaceuticals, software, and entertainment—over public interest. Several non-governmental organizations, such as, Doctors Without Borders and Public Citizen, have criticized the report for jeopardizing access to affordable medicine, particularly in impoverished economies, and disregarding TRIPS-compliant public health policies.
The report is not only subjective, but also selective. It frequently ignores genuine progress. Countries are often listed repeatedly despite legislative improvements. For instance, India’s reduction in patent backlogs and enhanced enforcement are overlooked. Lack of transparency and objectivity undermines credibility and reduces the incentive for countries to cooperate.
India is often placed on the Priority Watch List for issues like patent delays, compulsory licensing, and weak enforcement. However, its IP laws are fully TRIPS-compliant. Its use of Section3(d) of the Patent Act, 1970, prevents evergreening and promotes affordable access to medicines—an approach endorsed by public health advocates worldwide.
China’s IP regime too is frequently targeted in the Special 301 Report for trade secret misappropriation, forced technology transfers, and online piracy. While some concerns are valid, the U.S. has taken aggressive unilateral actions—such as tariffs—without fully resorting to WTO mechanisms. The WTO has ruled against some of these measures, primarily citing violations of Most-Favoured-Nation treatment.
It is obvious from the foregoing that the use of unilateral tariffs and sanctions based on Special 301 findings may contravene WTO rules on non-discrimination and due process. Article 1(1) provides that member-countries may optionally implement in their law more extensive protection than is required by this Agreement, provided that such protection does not contravene the provisions of this Agreement. But, unilateral measures under Special 301 Report ipso facto transgress provisions of TRIPS and trample upon the rights of other members to legislate “more rigorous” IP laws that are not in contravention thereof.
Further, the unilateral action violates the flexibilities afforded under Articles 7, 8and 31, which permit balancing IP rights with public health, technology access and development needs. Such measures that transgress ex facie Article 4 of the Agreement, which provides that benefits, such as most-favoured nation status, granted to one WTO member must be extended to all members.
The bypass and repudiation of formal arbitration processes before the Dispute Settlement Body (DSB) is also an infringement of the TRIPS Agreement. In fact, a WTO panel in 2020 ruled that tariffs imposed on China violated MFN obligations. Hence, there is also a growing call among Global South countries and advocacy groups for a collective response to the report's influence, possibly through WTO reforms or regional alliances.
To reconcile the Special 301 mechanism with international law and equity, several reforms are essential. To begin with the assessments must not only be aligned with TRIPS obligations, but also avoid TRIPS-plus coercion. TRIPS flexibilities, particularly for public health and development, must be recognized and respected. Further, the procedures must enhance transparency, allowing countries to present evidence and defend their policies.
The United States Trade Representative (USTR) must look beyond lobby groups and routinely involve stakeholder consultations in its processes. It must encourage multilateral solutions, rather than imposing unilateral pressure.
The Special301 Report serves as a powerful tool in the U.S. trade arsenal, aimed at enhancing IP protection globally. However, its unilateral nature, bias for US commercial interests, and disregard for WTO norms raise significant concerns. By pressuring countries to adopt TRIPS-plus standards and overlooking legitimate use of TRIPS flexibilities, the report undermines the multilateral, balanced, and development-oriented ethos of the TRIPS Agreement.
As global trade becomes increasingly interdependent, the need for collaborative, transparent, and rules-based IP governance is more urgent than ever. For the international IP system to be fair and sustainable, instruments like the Special 301 Report must evolve—or risk further fragmenting the delicate balance between innovation, access, and sovereignty within the comity of nations.
